{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T05:55:15Z","timestamp":1783662915377,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004349","name":"BASF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.tox.2024.153828","type":"journal-article","created":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T15:18:41Z","timestamp":1715440721000},"page":"153828","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Mode of action analysis for fluxapyroxad-induced rat liver tumour formation: evidence for activation of the constitutive androstane receptor and assessment of human relevance"],"prefix":"10.1016","volume":"505","author":[{"given":"Manuela","family":"Goettel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Honarvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibylle","family":"Gr\u00f6ters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Fegert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Haines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynsey R.","family":"Chatham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Vardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian G.","family":"Lake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2024.153828_bib1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0940-2993(97)80006-1","article-title":"Lobule-dependent zonal measurement (LZM) method for the determination of cell proliferation in the liver","volume":"49","author":"Bahnemann","year":"1997","journal-title":"Exp. Toxic. Pathol."},{"key":"10.1016\/j.tox.2024.153828_bib2","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/10408440600977677","article-title":"IPCS framework for analysing the relevance of a cancer mode of action for humans","volume":"36","author":"Boobis","year":"2006","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.tox.2024.153828_bib3","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0006-2952(94)90363-8","article-title":"Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver","volume":"48","author":"Burke","year":"1994","journal-title":"Biochem. Pharmacol.."},{"key":"10.1016\/j.tox.2024.153828_bib4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.toxlet.2017.05.006","article-title":"Mode of action and human relevance of THF-induced mouse liver tumors","volume":"276","author":"Choi","year":"2017","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.tox.2024.153828_bib5","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1177\/0192623310363813","article-title":"Evaluation of possible carcinogenic risk to humans based on liver tumors in rodent assays: the two-year bioassay is no longer necessary","volume":"38","author":"Cohen","year":"2010","journal-title":"Toxicol. Pathol."},{"issue":"S1","key":"10.1016\/j.tox.2024.153828_bib6","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1093\/toxsci\/kfq365","article-title":"Chemical carcinogenesis","volume":"120","author":"Cohen","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2024.153828_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/toxsci\/kfp006","article-title":"Mode of action analysis for the synthetic pyrethroid metofluthrin-induced rat liver tumors: evidence for hepatic CYP2B induction and hepatocyte proliferation","volume":"108","author":"Deguchi","year":"2009","journal-title":"Toxicol. Sci.."},{"key":"10.1016\/j.tox.2024.153828_bib8","unstructured":"ECHA, 2018. Committee for Risk Assessment (RAC). Opinion proposing harmonised classification and labelling at EU level of Fluxapyroxad. CLH-O-0000001412-86-254\/F. \u3008https:\/\/echa.europa.eu\/documents\/10162\/f21ff9a9-fbec-7faf-bc9e-c126f329599f\u3009."},{"key":"10.1016\/j.tox.2024.153828_bib9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3109\/10408444.2013.835786","article-title":"Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: a case study with phenobarbital as a model constitutive androstane receptor (CAR) activator","volume":"44","author":"Elcombe","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.tox.2024.153828_bib10","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1124\/dmd.117.075788","article-title":"Creation and preliminary characterization of pregnane X receptor and constitutive androstane receptor knockout rats","volume":"45","author":"Forbes","year":"2017","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2024.153828_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2020.152394","article-title":"Comparative studies on the effects of sodium phenobarbital and two other constitutive androstane receptor (CAR) activators on induction of cytochrome P450 enzymes and replicative DNA synthesis in cultured hepatocytes from wild type and CAR knockout rats","volume":"433-434","author":"Goettel","year":"2020","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2024.153828_bib12","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/019262301753385979","article-title":"Compendium of chemical carcinogens by target organ: results of chronic bioassays in rats, mice, hamsters, dogs, and monkeys","volume":"29","author":"Gold","year":"2001","journal-title":"Toxicol. Pathol.."},{"key":"10.1016\/j.tox.2024.153828_bib13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.tox.2018.03.002","article-title":"Comparison of the hepatic and thyroid gland effects of sodium phenobarbital in wild type and constitutive androstane receptor (CAR) knockout rats and pregnenolone-16\u03b1-carbonitrile in wild type and pregnane X receptor (PXR) knockout rats","volume":"400-401","author":"Haines","year":"2018","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2024.153828_bib14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tox.2018.02.001","article-title":"Comparison of the effects of sodium phenobarbital in wild type and humanized constitutive androstane receptor (CAR)\/pregnane X receptor (PXR) mice and in cultured mouse, rat and human hepatocytes","volume":"396-397","author":"Haines","year":"2018","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2024.153828_bib15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.tox.2009.01.007","article-title":"Comparison of the effects of the synthetic pyrethroid metofluthrin and phenobarbital on CYP2B form induction and replicative DNA synthesis in cultured rat and human hepatocytes","volume":"258","author":"Hirose","year":"2009","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2024.153828_bib16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1289\/ehp.9193247","article-title":"Chemicals associated with site-specific neoplasia in 1394 long-term carcinogenesis experiments in laboratory rodents","volume":"93","author":"Huff","year":"1991","journal-title":"Environ. Health Perspect.."},{"key":"10.1016\/j.tox.2024.153828_bib17","unstructured":"JMPR (Joint FAO\/WHO Meeting on Pesticide Residues), Pesticide residues in food- Toxicological evaluations. 2012. Fluxapyroxad 363-545."},{"key":"10.1016\/j.tox.2024.153828_bib18","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/00498250903098184","article-title":"Species differences in the hepatic effects of inducers of CYP2B and CYP4A subfamily forms: relationship to rodent liver tumour formation","volume":"39","author":"Lake","year":"2009","journal-title":"Xenobiotica"},{"key":"10.1016\/j.tox.2024.153828_bib19","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1039\/c8tx00008e","article-title":"Human relevance of rodent liver tumour formation by constitutive androstane receptor (CAR) activators","volume":"7","author":"Lake","year":"2018","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.tox.2024.153828_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CEJ.0b013e32836014c8","article-title":"A review of epidemiological data on epilepsy, phenobarbital, and risk of liver cancer","volume":"23","author":"La Vecchia","year":"2014","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.tox.2024.153828_bib21","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0009-2797(90)90075-X","article-title":"Induction of hepatic cytochrome P-450 mediated alkoxyresorufin O-dealkylase activities in different species by prototype P-450 inducers","volume":"75","author":"Lubet","year":"1990","journal-title":"Chem. -Biol. Interact."},{"key":"10.1016\/j.tox.2024.153828_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jat.2949","article-title":"New developments in the evolution and application of the WHO\/IPCS framework on mode of action\/species concordance analysis","volume":"34","author":"Meek","year":"2014","journal-title":"J. Appl. Toxicol.."},{"key":"10.1016\/j.tox.2024.153828_bib23","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jat.2984","article-title":"Mode of action human relevance (species concordance) framework: evolution of the Bradford Hill considerations and comparative analysis of weight of evidence","volume":"34","author":"Meek","year":"2014","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.tox.2024.153828_bib24","unstructured":"OECD, 1998. OECD Series on Principles of Good Laboratory Practice and Compliance Monitoring Number 1. OECD Principles on Good Laboratory Practice (as revised in 1997). ENV\/MC\/CHEM(98)17."},{"key":"10.1016\/j.tox.2024.153828_bib25","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1039\/C7TX00163K","article-title":"Candidate genes responsible for early key events of phenobarbital-promoted mouse hepatocellular tumorigenesis based on differentiation of regulating genes between wild type mice and humanized chimeric mice","volume":"6","author":"Ohara","year":"2017","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.tox.2024.153828_bib26","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2131\/jts.42.773","article-title":"Evaluation of the human relevance of the constitutive androstane receptor-mediated mode of action for rat hepatocellular tumor formation by the synthetic pyrethroid momfluorothrin","volume":"42","author":"Okuda","year":"2017","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.tox.2024.153828_bib27","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/toxsci\/kfx102","article-title":"Mode of action analysis for rat hepatocellular tumors produced by the synthetic pyrethroid momfluorothrin: evidence for activation of the constitutive androstane receptor and mitogenicity in rat hepatocytes","volume":"158","author":"Okuda","year":"2017","journal-title":"Toxicol. Sci."},{"issue":"S1","key":"10.1016\/j.tox.2024.153828_bib28","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1093\/toxsci\/kfq338","article-title":"Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities","volume":"120","author":"Omiecinski","year":"2011","journal-title":"Toxicol. Sci.."},{"key":"10.1016\/j.tox.2024.153828_bib29","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/10408440902914014","article-title":"Mode-of-action analysis for induction of rat liver tumors by pyrethrins: relevance to human cancer risk","volume":"39","author":"Osimitz","year":"2009","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.tox.2024.153828_bib30","first-page":"1143","article-title":"Testing for induction of DNA synthesis in human hepatocyte primary cultures by rat liver tumor promoters","volume":"51","author":"Parzefall","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.tox.2024.153828_bib31","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1080\/00498250110074063","article-title":"Evaluation of 7-benzyloxy-4-trifluoromethylcoumarin, some other 7-hydroxy-4-trifluoromethylcoumarin derivatives and 7-benzyloxyquinoline as fluorescent substrates for rat hepatic cytochrome P450 enzymes","volume":"31","author":"Renwick","year":"2001","journal-title":"Xenobiotica"},{"key":"10.1016\/j.tox.2024.153828_bib32","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.tiv.2016.08.006","article-title":"Development of an in vitro high content imaging assay for quantitative assessment of CAR-dependent mouse, rat, and human primary hepatocyte proliferation","volume":"36","author":"Soldatow","year":"2016","journal-title":"Toxicol. Vitr."},{"key":"10.1016\/j.tox.2024.153828_bib33","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1007\/s00204-022-03338-7","article-title":"Proteomic analysis of hepatic effects of phenobarbital in mice with humanized liver","volume":"96","author":"Sprenger","year":"2022","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2024.153828_bib34","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1007\/s00415-020-10379-4","article-title":"Anti-seizure medication is not associated with an increased risk to develop cancer in epilepsy patients","volume":"286","author":"Stritzelberger","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.tox.2024.153828_bib35","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1293\/tox.25.189","article-title":"Comparative histomorphological review of rat and human hepatocellular proliferative lesions","volume":"25","author":"Thoolen","year":"2012","journal-title":"J. Toxicol. Pathol."},{"key":"10.1016\/j.tox.2024.153828_bib36","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.yrtph.2014.09.011","article-title":"Liver tumor formation in female rat induced by fluopyram is mediated by CAR\/PXR nuclear receptor activation","volume":"70","author":"Tinwell","year":"2014","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.tox.2024.153828_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2019.152282","article-title":"Metazachlor: Mode of action analysis for rat liver tumour formation and human relevance","volume":"426","author":"Wiemann","year":"2019","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2024.153828_bib38","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1039\/c7tx00288b","article-title":"Case examples of an evaluation of the human relevance of the pyrethroids\/pyrethrins-induced liver tumours in rodents based on the mode of action","volume":"7","author":"Yamada","year":"2018","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.tox.2024.153828_bib39","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/10408444.2021.1939654","article-title":"Critical evaluation of the human relevance of the mode of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR)","volume":"51","author":"Yamada","year":"2021","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.tox.2024.153828_bib40","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1039\/C4TX00217B","article-title":"Lack of effect of metofluthrin and sodium phenobarbital on replicative DNA synthesis and Ki-67 mRNA expression in cultured human hepatocytes","volume":"4","author":"Yamada","year":"2015","journal-title":"Toxicol. Res.."},{"key":"10.1016\/j.tox.2024.153828_bib41","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/toxsci\/kfaa125","article-title":"Comparison of the hepatic effects of phenobarbital in chimeric mice containing either rat or human hepatocytes with humanized constitutive androstane receptor and pregnane X receptor mice","volume":"177","author":"Yamada","year":"2020","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2024.153828_bib42","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/toxsci\/kfu173","article-title":"Human hepatocytes support the hypertrophic but not the hyperplastic responses to the murine nongenotoxic hepatocarcinogen sodium phenobarbital in an in vivo study using a chimeric mouse with humanized liver","volume":"142","author":"Yamada","year":"2014","journal-title":"Toxicol. Sci."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X24001094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X24001094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T21:01:45Z","timestamp":1737752505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X24001094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":42,"alternative-id":["S0300483X24001094"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2024.153828","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mode of action analysis for fluxapyroxad-induced rat liver tumour formation: evidence for activation of the constitutive androstane receptor and assessment of human relevance","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2024.153828","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"153828"}}